BACKGROUND AND OBJECTIVES: Trichomoniasis is a prevalent cause of vaginitis among adolescents that increases the risk of acquiring other sexually transmitted diseases and of negative pregnancy outcomes. Treatment of trichomoniasis is therefore essential for improving sexual and reproductive health outcomes. A timely, sensitive diagnostic test for T vaginalis may increase the accuracy of clinician's treatment decisions, resulting in more infected women receiving treatment and fewer uninfected women receiving treatment. METHODS: This study was a retrospective observational assessment of electronic medical records before and after point-of-care (POC) implementation of the rapid antigen test. Records were collected from women aged 14 to 20 years who received a T vaginalis test in the emergency department during either study period. The main outcome measures were rates of accurate treatment, inaccurate treatment, and missed treatment of trichomoniasis in each study period. RESULTS: Overall rates of accurate treatment increased from 78.7% pre-POC to 87.7% post-POC (P = .02). Specifically, rates of not treating uninfected women increased from 61.4% pre-POC to 70.4% post-POC (P = .06), and rates of treating infected women were the same pre-POC (17.3%) and post-POC (17.3%; P = .99). Rates of inaccurate treatment decreased from 23.1% pre-POC to 13.1% post-POC (P = .02). Changes in missed treatment rates (14.0% pre-POC; 8.8% post-POC; P = .73) were not statistically significant. CONCLUSIONS: POC testing can improve clinical care by decreasing the use of antibiotics in uninfected women. The results of this study support the use of a T vaginalis rapid antigen POC test for adolescents presenting to the emergency department.
BACKGROUND AND OBJECTIVES:Trichomoniasis is a prevalent cause of vaginitis among adolescents that increases the risk of acquiring other sexually transmitted diseases and of negative pregnancy outcomes. Treatment of trichomoniasis is therefore essential for improving sexual and reproductive health outcomes. A timely, sensitive diagnostic test for T vaginalis may increase the accuracy of clinician's treatment decisions, resulting in more infected women receiving treatment and fewer uninfected women receiving treatment. METHODS: This study was a retrospective observational assessment of electronic medical records before and after point-of-care (POC) implementation of the rapid antigen test. Records were collected from women aged 14 to 20 years who received a T vaginalis test in the emergency department during either study period. The main outcome measures were rates of accurate treatment, inaccurate treatment, and missed treatment of trichomoniasis in each study period. RESULTS: Overall rates of accurate treatment increased from 78.7% pre-POC to 87.7% post-POC (P = .02). Specifically, rates of not treating uninfected women increased from 61.4% pre-POC to 70.4% post-POC (P = .06), and rates of treating infected women were the same pre-POC (17.3%) and post-POC (17.3%; P = .99). Rates of inaccurate treatment decreased from 23.1% pre-POC to 13.1% post-POC (P = .02). Changes in missed treatment rates (14.0% pre-POC; 8.8% post-POC; P = .73) were not statistically significant. CONCLUSIONS: POC testing can improve clinical care by decreasing the use of antibiotics in uninfected women. The results of this study support the use of a T vaginalis rapid antigen POC test for adolescents presenting to the emergency department.
Authors: B Nathan; J Appiah; P Saunders; D Heron; T Nichols; R Brum; S Alexander; P Baraitser; C Ison Journal: Int J STD AIDS Date: 2014-05-22 Impact factor: 1.359
Authors: C C Wang; R S McClelland; M Reilly; J Overbaugh; S R Emery; K Mandaliya; B Chohan; J Ndinya-Achola; J Bwayo; J K Kreiss Journal: J Infect Dis Date: 2001-02-28 Impact factor: 5.226
Authors: R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten Journal: J Infect Dis Date: 2007-01-22 Impact factor: 5.226
Authors: Jennifer L Reed; Lauren Simendinger; Sarah Griffeth; Hye Grace Kim; Jill S Huppert Journal: J Adolesc Health Date: 2009-10-12 Impact factor: 5.012
Authors: Purnima Madhivanan; Karl Krupp; Jill Hardin; Chitra Karat; Jeffrey D Klausner; Arthur L Reingold Journal: Trop Med Int Health Date: 2009-04-20 Impact factor: 2.622
Authors: Jill S Huppert; Frank Biro; Dongmei Lan; Joel E Mortensen; Jennifer Reed; Gail B Slap Journal: J Adolesc Health Date: 2007-03-09 Impact factor: 5.012
Authors: Charlotte A Gaydos; Jeffrey D Klausner; Nitika Pant Pai; Helen Kelly; Cordelia Coltart; Rosanna W Peeling Journal: Sex Transm Infect Date: 2017-07-06 Impact factor: 3.519
Authors: Lea E Widdice; Yu-Hsiang Hsieh; Barbara Silver; Mathilda Barnes; Perry Barnes; Charlotte A Gaydos Journal: Sex Transm Dis Date: 2018-11 Impact factor: 2.830
Authors: Yu-Hsiang Hsieh; Mitra K Lewis; Valentina G Viertel; Deanna Myer; Richard E Rothman; Charlotte A Gaydos Journal: Int J STD AIDS Date: 2020-09-30 Impact factor: 1.359
Authors: Giorgia Caruso; Anna Giammanco; Roberta Virruso; Teresa Fasciana Journal: Int J Environ Res Public Health Date: 2021-01-25 Impact factor: 3.390